PORTAF - postoperative radiotherapy of non-small cell lung cancer: accelerated versus conventional fractionation ; study protocol for a randomized controlled trial

In early-stage non-small cell lung cancer (NSCLC) without affected lymph nodes detected at staging, surgical resection is still the mainstay of treatment. However, in patients with metastatic mediastinal lymph nodes (pN2) or non-radically resected primary tumors (R1/R2), postoperative radiotherapy (...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bütof, Rebecca (VerfasserIn) , Simon, M. (VerfasserIn) , Löck, S. (VerfasserIn) , Troost, E. G. C. (VerfasserIn) , Appold, S. (VerfasserIn) , Krause, M. (VerfasserIn) , Baumann, Michael (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 20 December 2017
In: Trials
Year: 2017, Jahrgang: 18, Heft: 1, Pages: 1-6
ISSN:1468-6694
DOI:10.1186/s13063-017-2346-0
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/s13063-017-2346-0
Volltext
Verfasserangaben:R. Bütof, M. Simon, S. Löck, E.G.C. Troost, S. Appold, M. Krause and M. Baumann

MARC

LEADER 00000caa a2200000 c 4500
001 1771831332
003 DE-627
005 20220820051214.0
007 cr uuu---uuuuu
008 210927s2017 xx |||||o 00| ||eng c
024 7 |a 10.1186/s13063-017-2346-0  |2 doi 
035 |a (DE-627)1771831332 
035 |a (DE-599)KXP1771831332 
035 |a (OCoLC)1341421546 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Bütof, Rebecca  |d 1986-  |e VerfasserIn  |0 (DE-588)1017287856  |0 (DE-627)690301081  |0 (DE-576)350777977  |4 aut 
245 1 0 |a PORTAF - postoperative radiotherapy of non-small cell lung cancer  |b accelerated versus conventional fractionation ; study protocol for a randomized controlled trial  |c R. Bütof, M. Simon, S. Löck, E.G.C. Troost, S. Appold, M. Krause and M. Baumann 
264 1 |c 20 December 2017 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 27.09.2021 
520 |a In early-stage non-small cell lung cancer (NSCLC) without affected lymph nodes detected at staging, surgical resection is still the mainstay of treatment. However, in patients with metastatic mediastinal lymph nodes (pN2) or non-radically resected primary tumors (R1/R2), postoperative radiotherapy (possibly combined with chemotherapy) is indicated. So far, investigations about time factors affecting postoperative radiotherapy have only examined the waiting time defined as interval between surgery and start of radiotherapy, but not the overall treatment time (OTT) itself. Conversely, results from trials on primary radio(chemo)therapy in NSCLC show that longer OTT correlates with significantly worse local tumor control and overall survival rates. This time factor of primary radio(chemo)therapy is thought to mainly be based on repopulation of surviving tumor cells between irradiation fractions. It remains to be elucidated if such an effect also occurs when patients with NSCLC are treated with postoperative radiotherapy after surgery (and chemotherapy). Our own retrospective data suggest an advantage of shorter OTT also for postoperative radiotherapy in this patient group. 
650 4 |a Acceleration 
650 4 |a Fractionation 
650 4 |a Non-small-cell lung cancer (NSCLC) 
650 4 |a Overall treatment time 
650 4 |a Phase II trial 
650 4 |a Postoperative radiotherapy 
650 4 |a Randomized clinical trial 
650 4 |a Time factor 
700 1 |a Simon, M.  |e VerfasserIn  |4 aut 
700 1 |a Löck, S.  |e VerfasserIn  |4 aut 
700 1 |a Troost, E. G. C.  |e VerfasserIn  |4 aut 
700 1 |a Appold, S.  |e VerfasserIn  |4 aut 
700 1 |a Krause, M.  |e VerfasserIn  |4 aut 
700 1 |a Baumann, Michael  |d 1962-  |e VerfasserIn  |0 (DE-588)131385399  |0 (DE-627)508500222  |0 (DE-576)298443244  |4 aut 
773 0 8 |i Enthalten in  |t Trials  |d London : BioMed Central, 2000  |g 18(2017), 1, Artikel-ID 608, Seite 1-6  |h Online-Ressource  |w (DE-627)326173552  |w (DE-600)2040523-6  |w (DE-576)107014556  |x 1468-6694  |7 nnas  |a PORTAF - postoperative radiotherapy of non-small cell lung cancer accelerated versus conventional fractionation ; study protocol for a randomized controlled trial 
773 1 8 |g volume:18  |g year:2017  |g number:1  |g elocationid:608  |g pages:1-6  |g extent:6  |a PORTAF - postoperative radiotherapy of non-small cell lung cancer accelerated versus conventional fractionation ; study protocol for a randomized controlled trial 
856 4 0 |u https://doi.org/10.1186/s13063-017-2346-0  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210927 
993 |a Article 
994 |a 2017 
998 |g 131385399  |a Baumann, Michael  |m 131385399:Baumann, Michael  |d 50000  |e 50000PB131385399  |k 0/50000/  |p 7  |y j 
999 |a KXP-PPN1771831332  |e 3981458869 
BIB |a Y 
SER |a journal 
JSO |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"role":"aut","family":"Bütof","given":"Rebecca","roleDisplay":"VerfasserIn","display":"Bütof, Rebecca"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Simon, M.","given":"M.","family":"Simon"},{"role":"aut","roleDisplay":"VerfasserIn","given":"S.","display":"Löck, S.","family":"Löck"},{"roleDisplay":"VerfasserIn","display":"Troost, E. G. C.","given":"E. G. C.","family":"Troost","role":"aut"},{"role":"aut","family":"Appold","roleDisplay":"VerfasserIn","display":"Appold, S.","given":"S."},{"family":"Krause","roleDisplay":"VerfasserIn","given":"M.","display":"Krause, M.","role":"aut"},{"family":"Baumann","display":"Baumann, Michael","roleDisplay":"VerfasserIn","given":"Michael","role":"aut"}],"title":[{"title":"PORTAF - postoperative radiotherapy of non-small cell lung cancer","subtitle":"accelerated versus conventional fractionation ; study protocol for a randomized controlled trial","title_sort":"PORTAF - postoperative radiotherapy of non-small cell lung cancer"}],"id":{"eki":["1771831332"],"doi":["10.1186/s13063-017-2346-0"]},"recId":"1771831332","name":{"displayForm":["R. Bütof, M. Simon, S. Löck, E.G.C. Troost, S. Appold, M. Krause and M. Baumann"]},"note":["Gesehen am 27.09.2021"],"physDesc":[{"extent":"6 S."}],"relHost":[{"id":{"zdb":["2040523-6"],"eki":["326173552"],"issn":["1468-6694","1745-6215"]},"recId":"326173552","pubHistory":["1.2000 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"text":"18(2017), 1, Artikel-ID 608, Seite 1-6","extent":"6","volume":"18","pages":"1-6","year":"2017","issue":"1"},"titleAlt":[{"title":"Current controlled trials in cardiovascular medicine"}],"title":[{"title":"Trials","title_sort":"Trials"}],"origin":[{"dateIssuedKey":"2000","publisher":"BioMed Central","dateIssuedDisp":"2000-","publisherPlace":"London"}],"note":["Gesehen am 26.09.22"],"physDesc":[{"extent":"Online-Ressource"}],"disp":"PORTAF - postoperative radiotherapy of non-small cell lung cancer accelerated versus conventional fractionation ; study protocol for a randomized controlled trialTrials","language":["eng"]}],"language":["eng"],"origin":[{"dateIssuedDisp":"20 December 2017","dateIssuedKey":"2017"}]} 
SRT |a BUETOFREBEPORTAFPOST2020